作者：
Siri,Lillegraven [1]
;
Nina,Paulshus Sundlisæter [2]
;
Anna-Birgitte,Aga [2]
;
Joseph,Sexton [2]
;
Inge Christoffer,Olsen [3]
;
Åse Stavland,Lexberg [4]
;
Tor Magne,Madland [5]
;
Hallvard,Fremstad [6]
;
Christian A,Høili [7]
;
Gunnstein,Bakland [8]
;
Cristina,Spada [9]
;
Hilde,Haukeland [10]
;
Inger Myrnes,Hansen [11]
;
Ellen,Moholt [2]
;
Till,Uhlig [2]
;
Daniel H,Solomon [12]
;
Désirée,van der Heijde [13]
;
Tore K,Kvien [14]
;
Espen A,Haavardsholm [2]
作者单位：
REMEDY Center for treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway siri.lillegraven@gmail.com.
[1]
REMEDY Center for treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway.
[2]
Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway.
[3]
Department of Rheumatology, Vestre Viken HF, Drammen, Norway.
[4]
Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
[5]
Department of Rheumatology, Møre og Romsdal Hospital Trust, Ålesund, Norway.
[6]
Department of Rheumatology, Østfold Hospital Trust, Moss, Norway.
[7]
Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway.
[8]
Department of Rheumatology, Revmatismesykehuset AS, Lillehammer, Norway.
[9]
Department of Rheumatology, Martina Hansens Hospital, Sandvika, Norway.
[10]
Deptartment of Rheumatology, Helgelandssykehuset, Mo i Rana, Norway.
[11]
Faculty of Medicine, University of Oslo, Oslo, Norway.
[12]
Division of Rheumatology, Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
[13]
Harvard Medical School, Boston, Massachusetts, USA.
[14]
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
[15]
DOI
10.1136/ard-2023-224476
PMID
37607809
发布时间
2024-02-21
换一批
换一批
